While dysfunction of the IGF pathway appears to be critically important in colorectal cancer carcinogenesis, much work is still needed to develop the best approach to integrating anti-IGFR therapy into the treatment of colorectal cancer. The gene discussed is IGF1; the disease is colorectal cancer.